MENU
YMAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Y-mAbs Therapeutics (YMAB) Ownership - Who owns Y-mAbs Therapeutics?
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
230 Park Avenue
Phone
+1 646 885-8505
Employees
100
Web
https://www.ymabs.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
388.04M
P/E Ratio
N/A
Total Cash
62.29M
Projected Growth
N/A
Total Debt
3.12M
Revenue
85.39M
Risk (Beta)
0.08
Dividend Yield
N/A
Total Cash/Share
1.37
Total Debt/Equity
N/A
Revenue/Share
1.90 USD as % of share price
Fundamentals
YMAB
Capitalization
388M
P/E Ratio
N/A
Risk (Beta)
0.08
Dividend Yield
N/A
Total Cash
62.3M
Total Cash/Share
1.37
Total Debt
3.12M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
1.90%
Revenue
85.4M
ROE
N/A
Book Value
87.5M
P/B Ratio
4.43
Cash Flow
N/A
Earnings
-0.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
4.00
Current Revenue Per Employee
182476.64
Dividends Per Share - Security
N/A
EBITDA
-26.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
86.37
Revenue To Assets
-17.01
Shares Held By Institutions
169M
Shares Outstanding - Current
45.4M
Total Liabilities
29.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
9.068
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. YMAB showed earnings on August 08, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of novel antibody therapeutics for oncology targets
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
230 Park Avenue
Phone
+1 646 885-8505
Employees
100
Web
https://www.ymabs.com